Lucia Novak, CRNP, nurse practitioner and president of Diabesity in North Bethesda, Maryland, and Eugene E. Wright, MD, consulting associate at Duke University in Durham, North Carolina, discuss cardiorenal risk reduction in patients with chronic kidney disease associated with type 2 diabetes (T2D) with persistent albuminuria, early signs of estimated glomerular filtration rate decline and albuminuria in T2D, and combination therapies that may be good treatment options in lowering urinary albumin-to-creatinine ratio.
Special Collections
